I see it as a portfolio allocation issue. If at low prices you put 25% of your fund into it on the basis that it was close to a one way bet, you may not feel so comfortable having 50% of your fund there 12 months later once the price has risen 100%. What I object to is the insinuation that anyone selling now is crazy or is being forced to do so by margin calls. And when you say "grossly undervalued call options", what do you assess the prospects of CHF achieving clinically significant endpoints to be --- 40% 50%, 60%, 70%, 80% or more ? I honestly don't know. But If the trial fails, that "call option" as you call it is worth zero.
MSB Trading - 2020, page-2828
-
- There are more pages in this discussion • 20,333 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |